131 related articles for article (PubMed ID: 2157836)
1. Effects of zidovudine on Friend virus complex infection in Rfv-3r/s genotype-containing mice used as a model for HIV infection.
Morrey JD; Warren RP; Okleberry KM; Burger RA; Johnston MI; Sidwell RW
J Acquir Immune Defic Syndr (1988); 1990; 3(5):500-10. PubMed ID: 2157836
[TBL] [Abstract][Full Text] [Related]
2. Suppression of murine retroviral disease by 2',3'-didehydro-2',3'-dideoxythymidine (D4T).
Sidwell RW; Hitchcock M; Okleberry KM; Burger RA; Warren RP; Morrey JD
Antiviral Res; 1992 Oct; 19(4):313-24. PubMed ID: 1334395
[TBL] [Abstract][Full Text] [Related]
3. Early-initiated zidovudine therapy prevents disease but not low levels of persistent retrovirus in mice.
Morrey JD; Okleberry KM; Sidwell RW
J Acquir Immune Defic Syndr (1988); 1991; 4(5):506-12. PubMed ID: 2016687
[TBL] [Abstract][Full Text] [Related]
4. Effect of imexon treatment on Friend virus complex infection using genetically defined mice as a model for HIV-1 infection.
Morrey JD; Warren RP; Okleberry KM; Burger RA; Chirigos MA; Sidwell RW
Antiviral Res; 1991 Jan; 15(1):51-65. PubMed ID: 2036000
[TBL] [Abstract][Full Text] [Related]
5. Requirement for CD4(+) T cells in the Friend murine retrovirus neutralizing antibody response: evidence for functional T cells in genetic low-recovery mice.
Super HJ; Brooks D; Hasenkrug K; Chesebro B
J Virol; 1998 Nov; 72(11):9400-3. PubMed ID: 9765497
[TBL] [Abstract][Full Text] [Related]
6. Elucidation of mode of retroviral-inhibitory effects of imexon through use of immune competent and severe combined immune deficiency (SCID) mice.
Morrey JD; Mead JR; Warren RP; Okleberry KM; Burger RA; Sidwell RW
Antiviral Res; 1992 Mar; 17(3):223-33. PubMed ID: 1314537
[TBL] [Abstract][Full Text] [Related]
7. Anti-Friend virus antibody is associated with recovery from viremia and loss of viral leukemia cell-surface antigens in leukemic mice. Identification of Rfv-3 as a gene locus influencing antibody production.
Doig D; Chesebro B
J Exp Med; 1979 Jul; 150(1):10-9. PubMed ID: 286744
[TBL] [Abstract][Full Text] [Related]
8. Antiproliferative effect of D-aspartic acid beta-hydroxamate (DAH) on Friend virus-infected erythropoietic progenitor cells.
Tournaire R; Arnaud S; Hamedi-Sangsari F; Malley S; Grange J; Blanchet JP; Doré JF; Vila J
Leukemia; 1994 Oct; 8(10):1703-7. PubMed ID: 7934166
[TBL] [Abstract][Full Text] [Related]
9. Methionine enkephalin combined with AZT therapy reduce murine retrovirus-induced disease.
Specter S; Plotnikoff N; Bradley WG; Goodfellow D
Int J Immunopharmacol; 1994 Nov; 16(11):911-7. PubMed ID: 7868296
[TBL] [Abstract][Full Text] [Related]
10. Filariae-Retrovirus Co-infection in Mice is Associated with Suppressed Virus-Specific IgG Immune Response and Higher Viral Loads.
Dietze KK; Dittmer U; Koudaimi DK; Schimmer S; Reitz M; Breloer M; Hartmann W
PLoS Negl Trop Dis; 2016 Dec; 10(12):e0005170. PubMed ID: 27923052
[TBL] [Abstract][Full Text] [Related]
11. Murine retroviral disease-enhancing effects of a pyrimidinone immunomodulator.
Warren RP; Morrey JD; Burger RA; Okleberry KM; Sidwell RW
Antiviral Res; 1992 Sep; 19(3):233-45. PubMed ID: 1444328
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic effects of diethylcarbamazine and 3'-azido-3'-deoxythymidine on feline leukemia virus lymphoma formation.
Nelson P; Sellon R; Novotney C; Devera C; Davidian M; English R; Tompkins M; Tompkins W
Vet Immunol Immunopathol; 1995 May; 46(1-2):181-94. PubMed ID: 7618257
[TBL] [Abstract][Full Text] [Related]
13. Bone marrow transplantation from Fv-4-resistant donors rescues Friend leukemia virus-infected mice from leukemia: a model of bone marrow transplantation therapy against retroviral infection.
Kitagawa M; Kamisaku H; Aizawa S; Sado T
Leukemia; 1994 Dec; 8(12):2200-6. PubMed ID: 7808008
[TBL] [Abstract][Full Text] [Related]
14. Effect of combination interleukin-3 (IL-3) and granulocyte-macrophage colony stimulating factor (GM-CSF) on hematopoiesis administered to retrovirus-infected immunodeficient mice receiving dose-escalation zidovudine (AZT).
Gallicchio VS; Hughes NK; Tse KF; Ling J; Gaines H; Bowen TE; Uluitu M
Int J Immunopharmacol; 1995 Nov; 17(11):865-78. PubMed ID: 8788116
[TBL] [Abstract][Full Text] [Related]
15. Molecular assessment of the potential combination therapy of cytokines with biphalin and AZT for Friend leukemia virus infection in vitro.
Tang JL; Lipkowski AW; Specter S
Pharmacol Rep; 2008; 60(2):190-8. PubMed ID: 18443380
[TBL] [Abstract][Full Text] [Related]
16. Alteration of cytokine levels in murine retrovirus infection: modulation by combination therapy.
Bowden R; Tate SM; Soto S; Specter S
Int J Immunopharmacol; 1999 Dec; 21(12):815-27. PubMed ID: 10606002
[TBL] [Abstract][Full Text] [Related]
17. Factors influencing zidovudine efficacy when administered at early stages of Friend virus infection in mice.
Sinet M; Desforges B; Launay O; Colin JN; Pocidalo JJ
Antiviral Res; 1991 Sep; 16(2):163-71. PubMed ID: 1799277
[TBL] [Abstract][Full Text] [Related]
18. Major histocompatibility complex class I gene controls the generation of gamma interferon-producing CD4(+) and CD8(+) T cells important for recovery from friend retrovirus-induced leukemia.
Peterson KE; Iwashiro M; Hasenkrug KJ; Chesebro B
J Virol; 2000 Jun; 74(11):5363-7. PubMed ID: 10799615
[TBL] [Abstract][Full Text] [Related]
19. Protection of mice against Friend retrovirus infection by vaccination with antigen-loaded, spleen-derived dendritic cells.
Reuter T; Heldmann M; Schimmer S; Schepers K; Dittmer U
Vaccine; 2004 Jul; 22(21-22):2686-9. PubMed ID: 15246598
[TBL] [Abstract][Full Text] [Related]
20. Reduced provirus burden and enhanced humoral immune function in AZT-treated SCID-feline mice inoculated with feline immunodeficiency virus.
Johnson CM; Selleseth DW; Ellis MN; Childers TA; Tompkins MB; Tompkins WA
Vet Immunol Immunopathol; 1995 May; 46(1-2):169-80. PubMed ID: 7618256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
